East Kent Hospitals University NHS Foundation Trust is one of the largest hospital trusts in England.

During the past decade, East Kent Hospitals University NHS Foundation Trust conducted 21 clinical trials. In the 10-year time frame, 21 clinical trials started and 4 clinical trials were completed, i.e. on average, 19% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 1 clinical trials were completed. i.e. 11.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "East Kent Hospitals University NHS Foundation Trust" #1 sponsor was "Gilead Sciences" with 3 trials, followed by "Hoffmann-La Roche" with 3 trials sponsored, "King's College London" with 2 trials sponsored, "University College, London" with 2 trials sponsored and "Cambridge University Hospitals NHS Foundation Trust" with 2 trials sponsored. Other sponsors include 8 different institutions and companies that sponsored additional 18 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "East Kent Hospitals University NHS Foundation Trust" #1 collaborator was "Cancer Research UK" with 2 trials as a collaborator, "Addenbrookes Charitable Trust" with 1 trials as a collaborator, "Applied Health Research Centre" with 1 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator and "BUPA Foundation" with 1 trials as a collaborator. Other collaborators include 22 different institutions and companies that were collaborators in the rest 32 trials.

According to Clinical.Site data, the most researched conditions in "East Kent Hospitals University NHS Foundation Trust" are "Chronic Lymphocytic Leukemia" (2 trials), "Diabetic Macular Edema" (2 trials), "Acromioclavicular; Dislocation" (1 trials), "Actual or Potential Nonvariceal Bleeding in the Upper Gastrointestinal (GI) Tract" (1 trials) and "COVID-19" (1 trials). Many other conditions were trialed in "East Kent Hospitals University NHS Foundation Trust" in a lesser frequency.

Most popular intervention types in "East Kent Hospitals University NHS Foundation Trust" are "Drug" (13 trials), "Other" (4 trials), "Device" (3 trials), "Behavioral" (2 trials) and "Procedure" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Idelalisib" (3 trials), "Rituximab" (3 trials), "Faricimab" (2 trials) and "Sham Procedure" (2 trials). Other intervention names were less common.

The vast majority of trials in "East Kent Hospitals University NHS Foundation Trust" are 22 trials for "All" genders, 1 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "East Kent Hospitals University NHS Foundation Trust". undefined are not yet recruiting, 6 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in East Kent Hospitals University NHS Foundation Trust, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in East Kent Hospitals University NHS Foundation Trust, 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 10 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 7 trials that are defined as “Not Applicable".

East Kent Hospitals University NHS Foundation Trust has several departments that took part in Clinical trials: "Kent & Canterbury Hospital; Clinical Haematology" - 2 trials